Gupta Sanchit, Seydel Karl, Miranda-Roman Miguel A, Feintuch Catherine M, Saidi Alex, Kim Ryung S, Birbeck Gretchen L, Taylor Terrie, Daily Johanna P
Department of Medicine, Division of Infectious Disease, Albert Einstein College of Medicine, Bronx, New York, United States of America.
Blantyre Malaria Project, University of Malawi College of Medicine, Blantyre, Malawi.
PLoS One. 2017 Apr 20;12(4):e0175686. doi: 10.1371/journal.pone.0175686. eCollection 2017.
Cerebral malaria (CM) presents as an encephalopathy and is due to infection with Plasmodium falciparum. Patients are comatose, often with fever, recurrent seizures and this condition is associated with a high mortality rate. The etiology of the coma and seizures are poorly understood. Circulating small molecules and lipids have bioactive functions and alterations in their concentrations have been implicated in seizure disorders and other forms of encephalopathy. We carried out a comprehensive analysis of blood metabolites during CM to explore a biochemical basis of this encephalopathy. A paired metabolomics analysis was performed on the plasma samples of Malawian children (n = 11) during CM and at convalescence thirty days later, to identify differentially abundant molecules associated with CM. We also report plasma molecules associated with CM mortality (n = 4) compared to survival (n = 19). Plasma metabolites were identified through ultra high performance liquid chromatography/tandem mass spectrometry and gas chromatography/mass spectrometry to maximize compound detection and accuracy and then compared to a library for identification. We detected a total of 432 small molecules in the plasma and 247 metabolites were significantly differentially abundant between CM and convalescence (p < 0.05, FDR < 0.10). These represented global changes across many classes of molecules including lipids, amino acids and hemoglobin metabolites. We observed significant changes in molecules that could impact neurologic function during CM; these include increased levels of kynurenate and decreased indolepropionate, glutamate, arginine and glutamine. Moreover, 1-methylimidazoleacetate, kyurenate, arachidonic acid and dimethylarginine were associated with mortality (p < 0.05, fold change > 1.2). These results highlight the broad changes in blood chemistry during CM. We have identified metabolites that may impact central nervous system physiology and disease outcomes and can be further explored for their mechanistic roles into the pathophysiology of CM.
脑型疟疾(CM)表现为脑病,由恶性疟原虫感染所致。患者昏迷,常伴有发热、反复惊厥,且该病症死亡率高。昏迷和惊厥的病因尚不清楚。循环小分子和脂质具有生物活性功能,其浓度变化与癫痫疾病及其他形式的脑病有关。我们对脑型疟疾患者的血液代谢物进行了全面分析,以探究这种脑病的生化基础。对马拉维儿童(n = 11)在脑型疟疾期间及30天后康复期的血浆样本进行了配对代谢组学分析,以确定与脑型疟疾相关的差异丰富分子。我们还报告了与脑型疟疾死亡率(n = 4)相比存活者(n = 19)的血浆分子情况。通过超高效液相色谱/串联质谱和气相色谱/质谱法鉴定血浆代谢物,以最大限度地提高化合物检测和准确性,然后与库进行比较以进行鉴定。我们在血浆中总共检测到432种小分子,其中247种代谢物在脑型疟疾和康复期之间存在显著差异丰富(p < 0.05,FDR < 0.10)。这些代表了包括脂质、氨基酸和血红蛋白代谢物在内的许多类分子的整体变化。我们观察到在脑型疟疾期间可能影响神经功能的分子有显著变化;这些包括犬尿烯酸水平升高以及吲哚丙酸、谷氨酸、精氨酸和谷氨酰胺水平降低。此外,1 - 甲基咪唑乙酸、犬尿烯酸、花生四烯酸和二甲基精氨酸与死亡率相关(p < 0.05,变化倍数> 1.2)。这些结果突出了脑型疟疾期间血液化学的广泛变化。我们已经鉴定出可能影响中枢神经系统生理学和疾病结局的代谢物,并可进一步探索它们在脑型疟疾病理生理学中的机制作用。